• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Tesaro

Anonymous board for Tesaro
Replies
14
Views
11K
anonymous
Replies
0
Views
650
anonymous
Replies
10
Views
5K
anonymous
Replies
7
Views
5K
anonymous
Replies
0
Views
3K
anonymous
Replies
2
Views
3K
anonymous
Replies
2
Views
3K
anonymous
Replies
2
Views
2K
anonymous
Replies
2
Views
2K
anonymous
Replies
2
Views
3K
anonymous
Replies
7
Views
3K
anonymous
Replies
10
Views
3K
anonymous
Replies
1
Views
3K
anonymous
Replies
0
Views
3K
anonymous
Replies
11
Views
6K
anonymous
Replies
0
Views
4K
anonymous
Replies
1
Views
6K
anonymous
Replies
0
Views
4K
anonymous
Replies
1
Views
5K
anonymous